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Background: A triple antibiotic mixture (ciprofloxacin; CF, metronidazole; MN, and minocycline; MC) has been used
for dental root canal medicaments in pulp regeneration therapy. However, tooth discolorations, cervical root
fractures, and inadequate pulp-dentin formation have been reported due to the triple antibiotic regimen. Therefore,
an antibiotic encapsulated biomimetic nanomatrix gel was developed to minimize the clinical limitations and
maximize a natural healing process in root canal infections. In this study, minimal bacterial concentrations (MBC) of
the selected antibiotics (CF and MN) were tested in 14 representative endodontic bacterial species. Then MBC of
each CF and MN were separately encapsulated within the injectable self-assembled biomimetic nanomatrix gel to
evaluate antibacterial level on Enterococcus faecalis and Treponema denticola.
Results: Antibiotic concentrations lower than 0.2 μg/mL of CF and MN demonstrated antibacterial activity on the
14 endodontic species. Furthermore, 6 different concentrations of CF and MN separately encapsulated with the
injectable self-assembled biomimetic nanomatrix gel demonstrated antibacterial activity on Enterococcus faecalis
and Treponema denticola at the lowest tested concentration of 0.0625 μg/mL.
Conclusions: These results suggest that each CF and MN encapsulated within the injectable self-assembled biomimetic
nanomatrix gel demonstrated antibacterial effects, which could be effective for the root canal disinfection while
eliminating MC. In the long term, the antibiotic encapsulated injectable self-assembled biomimetic nanomatrix
gel can provide a multifunctional antibiotic delivery method with potential root regeneration. Further studies are
currently underway to evaluate the effects of combined CF and MN encapsulated within the injectable
self-assembled biomimetic nanomatrix gel on clinical samples.
Keywords: Ciprofloxacin, Metronidazole, Enterococcus faecalis, Treponema denticola, Injectable self-assembled
biomimetic nanomatrix gelBackground
Dental pulp tissue exposed to mechanical trauma or
cariogenic processes can result in root canals and/or
periapical infections, which can be treated with end-
odontic procedure (root canal treatment) [1]. Infected* Correspondence: pedopjh@khu.ac.kr; kcheon@uab.edu
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unless otherwise stated.teeth with immature root structure require a root end
closure treatment (apexification) by Ca(OH)2 or mineral
trioxide aggregate [2]. Yet the apexification method has
been shown to result in poor pulp-dentin tissue forma-
tion. In order to regenerate pulp-dentin tissue in the in-
fected immature root, a revascularization procedure has
been applied using a triple antibiotics mixture, ciproflox-
acin (CF), metronidazole (MN), and minocycline (MC),
along with NaOCl irrigation and Ca(OH)2 [3-5]. How-
ever, the traditional revascularization treatment has been
implicated in several adverse clinical outcomes including. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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pulp-dentin tissue formation [6-8].
The regenerative tissue engineering concept has grown
in the field of medicine. Its main contributors include
pluripotent cells, signaling molecules, and scaffold sys-
tem which is to capture characteristic properties of nat-
ural extracellular matrix (ECM) which plays a key role in
tissue development [9-11]. The scaffolds can be synthe-
sized by variety of recent nanotechnology including self-
assembly, electrospinning and thermal inducing phase
separation characterized by biocompatibility and bio-
degradability [10,12]. Among the nanotechnology, a bio-
mimetic nanomatrix gel is formed by self-assembled
peptide amphiphiles (PAs), which consist of a hydro-
philic functional peptide sequence attached to a hydro-
phobic alkyl tail. Due to their amphiphilic characteristics
and molecular shape, PAs can self-assemble into highly
ordered ECM like nanostructures in optimal pH [13,14].
In addition, manipulative viscoelastic properties of PA
structure allows for replication of the essential properties
of the ECM environment [12,15-17]. Thus the biomim-
etic nanomatrix gel contains several functional units;
scaffolding self-assembled nanofibers, injectable visco-
elastic properties, encapsulation of cells or antibiotics at
physiological conditions, releasing of antibiotics in a
highly controlled manner, cell adhesive ligands, and
enzyme-mediated degradable sites [16,18]. With these
functional benefits, the biomimetic nanomatrix gel was
considered to be applied to the regenerative endodon-
tics; antibiotic molecules can be encapsulated within the
self-assembled biomimetic nanomatrix gel to be released
in controlled manner inside root canal, which can re-
duce the antibiotic concentrations compared to the
triple antibiotic mixture; unique viscoelastic property of
the nanomatrix gel enables direct injection into the in-
fected root canal space; the ECM mimicking self-
assembled PAs can promote interaction with surrounding
pulp tissues. While the conventional triple mixture was
mixed manually with nonfunctional and non-bioactive
paste.
The goals of the successful endodontic regeneration
therapy can be demonstrated by a lacking of post-
treatment clinical symptoms and radiographic evidence
of continued root development [3]. To achieve the goals,
efficient root canal disinfection and adequate root dentin
formation are proposed using antibiotics encapsulated
injectable self-assembled biomimetic nanomatrix gel. In
this study, minimal bactericidal concentrations (MBC)
from the triple antibiotics, CF, MN excluding MC, were
tested to determine bactericidal activity against 14 end-
odontic species. Augmentin (AM) was also tested as a
potential alternative to MC to reduce the unfavorable
tooth discoloration associated with the conventional triple
mixture. Consequently, predetermined concentrations ofthe each antibiotic were encapsulated within the injectable
biomimetic nanomatrix gel and evaluated its bactericidal
activity on Enterococcus faecalis and Treponema denticola.
E. faecalis and T. denticola were selected as the facultative
and strict anaerobic species among the above 14 endodon-
tic species.
Methods
Antibiotics and agar dilution preparation
The antibiotics, CF (Nelson Pharm Korea®, Seoul,
Korea), MN (Cheil Jedang®, Seoul, Korea) and AM (Il-
Sung Shin Yak®, Seoul, Korea), were provided by powder
form and mixed with propylene glycol [5]. Each anti-
biotic was serially diluted in 2-fold from starting concen-
tration 5 μg/mL and mixed with sterilized 1.5% agar
supplemented with Brucella broth, Vitamin K1, Hemin
solution, and supplemented with 5% defibrinated sheep
blood in pH 7.2 as manufacture recommended (Becton,
Dickinson and Company, Franklin Lakes, NJ, USA). Two
mL of the mixed solution of the antibiotic and the media
was distributed to the each well of 24 well-plates. Posi-
tive controls were prepared with 1 μL from 10-fold serial
dilution of the bacteria culture broth without antibiotics.
Antibiotics without bacterial species served as the nega-
tive control. Following preparation of the controls, the
plates incubated overnight at room temperature.
Bacterial species and culture
Fourteen bacteria species [19] which have been fre-
quently observed from root canal infection were selected
for the antibiotic susceptibility tests. The bacteria are
Aggregatibacter actinomycetemcomitans (Aa), Fusobac-
terium nucleatum (Fn), Porphyromonas endodontalis
(Pe), Porphyromonas gingivalis (Pg), Prevotella nigresens
(Pn), Prevotella intermedia (Pi), Tennerella forsythia
(Tf ), Treponema denticola (Td), Enterococcus faecalis
(Ef ), Lactobacillus casei (Lc), Streptococcus gordonii (Sg),
Streptococcus mutans (Sm), Streptococcus sobrinus (Sso),
and Streptococcus sanguinis (Ssa). Each of the 14 bacter-
ial species were incubated in anaerobic condition for
48 hours on Brucella blood agar plates; then several col-
onies were inoculated in suspension of 10 mL Brucella
broth and incubated for 6 hrs anaerobically at 37°C as
shown in the Table 1. The bacterial density from the
suspensions was adjusted with sterile Brucella broth to
equivalent by the 0.5 McFarland standard and the optical
density (OD) value was adjusted to 0.1 [20]. From the
adjusted broth culture of the 14 species, 1 μL was
dropped in 5 different locations onto prepared the 1.5%
agar in 24 well-plates within 15 minutes. Then the plates
were incubated anaerobically at 37°C for 1–7 days de-
pending on the species [21].
The data was initially measured as Minimal Inhibitory
Concentration (MIC); however, the MIC can be considered
Table 1 Common bacterial species found in endodontic root canals and culture condition
Bacterial species Source Media Condition
Liquid Solid
A. actinomycetemcomitans Y4 BHI broth BHI + agar 37°C, 5% CO2
F. nucleatum ATCC 23726 BHI broth BHI + agar 37°C, Anaerobic
P. endodontalis ATCC 35496 Pg broth Blood agar 37°C, Anaerobic
P. gingivalis 2561 Pg broth Blood agar 37°C, Anaerobic
P. nigrescens ATCC 33563 Pg broth Blood agar 37°C, Anaerobic
P. intermedia ATCC 25611 Pg broth Blood agar 37°C, Anaerobic
T. forsythia ATCC 43037 PY borth NAM medium 37°C, Anaerobic
T. denticola ATCC 3521 TYGVS TYGVS + agar 37°C, Anaerobic
E. faecalis ATCC 4083 BHI broth BHI + agar 37°C, Facultative
L. casei HY 2782 MRS MRS + agar 37°C, Facultative
S. gordonii G9B BHI broth BHI + agar 37°C, Facultative
S. mutans GS5 BHI broth BHI + agar 37°C, Facultative
S. sobrinus 6715 BHI broth BHI + agar 37°C, Facultative
S. sanguinis clinical isolates BHI broth BHI + agar 37°C, Facultative
BHI: Brain-heart infusion, Pg: Porphyromonas gingivalis , TYGVS: tryptone-yeast extract-gelatin-volatile fatty acids-serum, MRS: deMan, Rogosa and Sharpe,
NAM: N-acetylmuramic acid.
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(bactericidal effects). For bactericidal drugs, the MBC is
usually the same as and generally not more than 4-fold
higher than the MIC [22]. Therefore, MBCs were deter-
mined by counting colony forming units (CFUs) at 99.9%
of bactericidal effect of each of the 14 species based on the
anaerobe antimicrobial susceptibility testing protocol [23].
Synthesis of peptide amphiphiles
The peptide amphiphiles (PAs) were synthesized using
standard Fmoc-chemistry on an Advanced Chemtech
Apex 396 peptide synthesizer (AAPPTec, Louisville, KY,
USA), as described before [14]. The three different pep-
tides, Tyr-Ile-Gly-Ser-Arg, (YIGSR, cell-adhesive ligand),
Lysine (KKKKK, NO donor), and Short (enhance gel-
ation) were synthesized to be 13 amino acids long and
contain the MMP-2 sensitive sequence (GTAGLIGQ)
[14]. Following the synthesis, the peptides were alkylated
through linkage to a 16 carbonpalmityl chain resulting in
PAs: PAs C16-GTAGLIGQ-YIGSR (PA-YIGSR), C16-GTA
GLIGQ-KKKKK (PA-KKKKK), and C16-GTAGLIGQ-S
(PA-Short). PA-YIGSR and PA-KKKKK were dissolved in
deionized water to prepare 1 wt % stock solutions. The
pH of these solutions was adjusted to 7.4 using a 1 M so-
dium hydroxide solution. PA-Short was dissolved in de-
ionized water to make a 2 wt % stock solution. The pH of
this solution was also adjusted to 7.4 in the same manner.
PA-YIGSR and PA-KKKKK were then mixed in a ratio 9
PA-YIGSR: 1 PA-KKKKK to form PA-YK. The 9:1 ratio
for PA-YK was selected due to its optimized perform-
ance in gelation as cell adhesion is significantly improved
with increasing PA-YIGSR concentration as previouslydemonstrated [24]. Then 25 μL of PA-YK and 25 μL of the
PA-Short solutions were placed in 12-well silicon inserts,
flexiPerm® (Sigma Aldrich, St. Louis, MO, USA), attached
to a glass cover slide.
Encapsulation of ciprofloxacin (CF) and metronidazole
(MN) in the biomimetic nanomatrix gel
After the screening of the 14 endodontic species, the an-
tibiotics CF (GenHunter, Nashville, TN, USA) and MN
(Sigma-Aldrich, St. Louis, MO, USA) were purchased
and separately prepared as 5 μg/mL stock solutions.
Then the antibiotic stock solutions were serially diluted
to concentrations of 0, 0.0625, 0.125, 0.25, 0.5 and 1 μg/
mL in 15 mL of DI water at pH 7.4. Ten μL of an aque-
ous solution of 0.1 M CaCl2 and 5 μL of the prepared
antibiotic solution were added to a cylindrical-shaped
silicone mold flexiPerm® to induce self-assembled anti-
biotic encapsulated within the biomimetic nanomatrix gel.
The cylindrical-shaped gel was preferred for the intra-
canal injectable biomimetic nanomatrix gel application.
Bacterial culture for E. faecalis and T. denticola
E. faecalis was cultured in Todd-Hewitt broth (THB)
and incubated aerobically with 37°C with 5% CO2 for
24 hours. Similarly, T. denticola was cultured in New
Oral Spirochete media (NOS) and grown in a Coy anaer-
obic chamber at 37°C for 24 hours. Overnight bacterial
cultures were sub-cultured by diluting 1/100 in THB or
NOS until the bacteria reached mid-log phase. To deter-
mine CFUs, E. faecalis was serially diluted and plated on
sheep blood agar (BD Falcon, Bedford, MA, USA) at
37°C for 24 hours. The bacterial densities from the broth
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standard with optical density (OD600); E. faecalis (6.2 ×
106 CFU/mL) and T. denticola (2.0 × 109 CFU/mL) were
used throughout the experiment [20,25]. As seen in
Figure 1, the CFUs were counted by serially diluted
cell suspension: 10−2, 10−4 and 10−6. Ten μL of each
serially diluted bacterial suspension was pipetted into
an Anaerobe Blood Agar Plate (BD Falcon, San Jose,
CA) and spread for 24 hr incubation. The plates were
visually inspected to determine the colony morphology
and counted for CFUs.
Evaluation of antibacterial effects of the antibiotic
encapsulated injectable biomimetic nanomatrix gel
The prepared cylindrical nanomatrix gels were removed
from the flexiPerm® and placed in the center of each
24well culture plate. One mL of the 24 hour-cultured
THB bacteria was evenly distributed in each of the wells
and incubated in aerobic or anaerobic condition, de-
pending on the bacteria, at 37°C for 24 hours. Positive
controls (antibiotic without nanomatrix gel) and negative
controls (bacteria only) were also included as shown in
Figure 2. The experiments were repeated 4 times for cal-
culation of the mean values. ODs were used to measure
bacterial loads at the variable antibiotic concentrationsFigure 1 Bacterial morphology and colony forming units (CFUs)/mL. Bacte
by sheep blood agar culture. Optical Density (600 nm) measured 10−4 dilut(0 μg/mL, 0.0625 μg/mL, 0.125 μg/mL, 0.25 μg/mL,
0.5 μg/mL and 1 μg/mL) using a spectrophotometer
(Beckman Coulter DU800, Brea, CA, USA). To determine
the bactericidal activity after 24 hour culture, ODs were
measured by collection of 500 μL from the each wells of
the 24 well bacteria culture plates and measured using a
disposable cuvette at a wavelength of 600 nm [26,27] using
a spectrophotometer.
Results
Minimal bactericidal concentration (MBC) of 3 antibiotics
Table 2 summarizes MBCs of the 3 antibiotics (CF, MN,
and AM), respectively for the 14 species cultures. The
MBCs for both CF and MN were 0.1 μg/mL in 6 species
(Aa, Fn, Pe, Pg, Pi, and Tf ) and 0.2 μg/mL in 5 species
(Ef, Sg, Sm, Sso, and Ssa). Meanwhile the MBC for AM
was required 2 to 5-fold higher concentrations to
achieve similar effect to CF and MN.
The effect of ciprofloxacin (CF) and metronidazole (MN)
against facultative anaerobic E. faecalis
CF was shown to have dose dependent antibacterial ef-
fect against the three different E. faecalis densities at the
lowest concentration of 0.0625 μg/mL (Figure 3A).
Figure 3B illustrated that the CF encapsulated biomimeticrial morphology and CFUs were verified with serial dilutions followed
ion tube.
Figure 2 General scheme of the experimental design. Antibiotic encapsulated biomimetic nanomatrix gel system was evaluated against the aerobic
bacteria, E. faecalis and anaerobic bacteria, T. denticola with three treatment conditions: CF, MN, and no antibiotic. A. Synthesis of peptide amphiphiles
(PAs), B. Self-assembly of PAs, C. Encapsulation of antibiotics, D. Formation of injectable nanomatrix gel and experiment design by with three options:
Positive control (antibiotic without biomimetic nanomatrix gel), Antibiotic (ciprofloxacin: CF and metronidazole: MN) encapsulated biomimetic
nanomatrix gel, Negative control (bacteria only).
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densities and had similar antibacterial effects as CF with-
out biomimetic nanomatrix gel.
The effect of the antibiotic MN was studied on the same
densities of E. faecalis as the CF experiments. In Figure 4,
interestingly the antibiotic MN was not as effective on E.
faecalis as CF was. The results of the MN encapsulated
with nanomatrix gel in same bacterial densities also did
not show antibacterial effect (Figure 4B).
The effect of ciprofloxacin and metronidazole against
anaerobic T. denticola
As seen in Figure 5A, the antibiotic CF against T. denti-
cola displayed complete bactericidal effect in the differ-
ent densities (2.0 × 106 CFU/mL and 2.0 × 107 CFU/
mL) at the concentration of 0.0625 μg/mL without bio-
mimetic nanomatrix gel. Similarly, the CF encapsulated
with biomimetic nanomatrix gel (Figure 5B) showed that
the antibacterial activity is effective at 0.0625 μg/mL
concentration to all bacterial densities including 2.0 ×
108 CFU/mL.
The antibacterial effect of MN was seen on the bac-
terium T. denticola with varying densities as shown in
Figure 6. Bactericidal effects were shown at 0.0625 μg/
mL of MN without encapsulation in an injectable self-
assembled biomimetic nanomatrix gel (Figure 6A) and
with encapsulation in an injectable self-assembled bio-
mimetic nanomatrix gel (Figure 6B).Discussion
Antimicrobial susceptibility test
Table 2 displays the MBCs of the three antibiotics (CF,
MN, and AM). CF interferes with DNA function in
bacteria such as aerobic and anaerobic gram-positive
bacteria and several mycobacterium species [28]. MN in-
terferes with bacterial DNA of gram-negative anaerobic
bacilli [29]. AM, a combination of amoxicillin and clavu-
lanate potassium, has shown great efficacy in dental
infection due to its broad spectrum and few adverse
effects [30,31]. AM was tested instead of MC which is
the most effective component; although its adverse effect
of tooth discoloration is detested in clinical applications
[6]. When the MBCs were converted to a ratio, it was
observed as 1:1:5 (CF: MN: AM) respectively in 11 spe-
cies (Aa, Fn, Pe, Pg, Pi, Tf, Ef, Sg, Sm, Sso, and Ssa),
which ratio reflect that AM required 2 to 5-fold higher
concentrations overall to achieve similar bactericidal ef-
fects compared to CF and MN. Therefore, AM was re-
moved from the nanomatrix encapsulation study due to
concern of increased concentration dosage affecting the
patients’ health. CF and MN have successfully been used
in intra-canal medicaments without incorporating a third
component, MC, and are commonly referred to as double
antibiotic paste [32]. Furthermore, our results indicate that
CF and MN can be effective with a 1:1 ratio concentration
than the triple antibiotic ratio (1:3) and agreed to the pre-
vious study [32].
Figure 3 The effect of ciprofloxacin (CF) against E. faecalis. Antibacterial
0.0625 μg/mL, 0.125 μg/mL, 0.25 μg/mL, 0.5 μg/mL and 1 μg/mL against E.
6.2 × 105 CFU/mL. A. Without nanomatrix gel, B. With antibiotic encapsulate
Table 2 Minimal bactericidal concentration (MBC) of
3 antibiotics measured for 14 bacterial species
Species MBC (μg/mL) Species MBC (μg/mL)
A. actinomycetemcomitans CF 0.1 T. denticola CF 0.1
MN 0.1 MN 0.25
AM 0.5 AM 0.5
F. nucleatum CF 0.1 E. faecalis CF 0.2
MN 0.1 MN 0.2
AM 0.5 AM 1
P. endodontalis CF 0.1 L. casei CF 1
MN 0.1 MN 0.5
AM 0.5 AM 2
P. gingivalis CF 0.1 S. gordonii CF 0.2
MN 0.1 MN 0.2
AM 0.5 AM 1
P. nigresens CF 0.25 S. mutans CF 0.2
MN 0.25 MN 0.2
AM 0.5 AM 1
P.intermedia CF 0.1 S. sobrinus CF 0.2
MN 0.1 MN 0.2
AM 0.5 AM 1
T. forsythia CF 0.1 S. sanguinis CF 0.2
MN 0.1 MN 0.2
AM 0.5 AM 1
CF: ciprofloxacin, MN: metronidazole, AM: Augmentin, MBC: minimal
bactericidal concentration.
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single antibiotic have shown that the concentrations of
0.024 μg/mL maintained dental pulp cell viability for dur-
ing 7 days [33] and more than 1 mg/mL can be a harmful
effect on dental pulp stem cell [34]. This supports our
results which demonstrated between 0.0625 μg/mL and
1 μg/mL for a single antibiotic bactericidal effect. Although
our data is preliminary, it suggests potential benefits to pa-
tients by reducing unfavorable antibiotic complications.
Further investigations will be required to confirm our find-
ings in clinical samples, which may include a complex of
endodontic bacteria.
Table 2 results also show that the latter 5 species (Ef,
Sg, Sm, Sso, and Ssa) among the 11 species with a 1:1:5
MBC ratio were all facultative anaerobes and required
an antibiotic concentration that was double that of the
other 6 species (Aa, Fn, Pe, Pg, Pi and Tf ). This may be
due to the survival capability of the facultative anaerobes
under the anaerobic environment. Particularly, E. faeca-
lis is known as normal commensal flora in the human
digestive system and often causes nosocomial infections
and has been shown to display antibiotic resistance. It is
also known as one of the main pathogens causing recur-
rent endodontic infections [35].
Selection of E. faecalis and T. denticola
Infective dental root canal consisted of a variety of bac-
teria; among the endodontic microbiota, E. faecalis and
T. denticola were selected as an initial microorganism to
be tested for antibiotic encapsulated self-assembled bio-
mimetic nanomatrix gel. E. faecalis, a gram-positive aer-
obic cocci and T. denticola, a gram-negative anaerobic
fusiform rod, are often found in endodontic infectionseffect of CF was measured in varying concentrations of 0 μg/mL,
faecalis in concentrations of 6.2 × 103 CFU/mL, 6.2 × 104 CFU/mL and
d in nanomatrix gel.
Figure 4 The effect of metronidazole (MN) against E. faecalis. Antibacterial effect of MN was measured in varying concentrations of 0 μg/mL,
0.0625 μg/mL, 0.125 μg/mL, 0.25 μg/mL, 0.5 μg/mL and 1 μg/mL on E. faecalis in concentrations of 6.2 × 103 CFU/mL, 6.2 × 104 CFU/mL and
6.2 × 105 CFU/mL. A. Without nanomatrix gel, B. With antibiotic encapsulated in nanomatrix gel.
Kaushik et al. Biomaterials Research  (2015) 19:9 Page 7 of 10and commonly used to evaluate endodontic disinfectants
[36,37]. As a pilot study, these two species in vitro stud-
ies demonstrated the optimal bactericidal concentrations
of antibiotic encapsulated injectable self-assembled bio-
mimetic nanomatrix gel delivery system.
Antibiotic encapsulation within the injectable
self-assembled biomimetic nanomatrix gel
As observed in Figures 3 and 5, when CF was encapsu-
lated in the injectable self-assembled biomimetic nanoma-
trix gel (Figures 3B and 5B), CF was successfully released
from the injectable self-assembled biomimetic nanomatrixFigure 5 The Effect of ciprofloxacin (CF) against T. denticola. Antibacterial e
0.0625 μg/mL, 0.125 μg/mL, 0.25 μg/mL, 0.5 μg/mL and 1 μg/mL on T. den
2.0 × 108 CFU/mL. A. Without nanomatrix gel, B. With antibiotic encapsulatgel and demonstrated similar bactericidal effect as anti-
biotic itself. This indicated that the injectable self-
assembled biomimetic nanomatrix gel did not restrict the
release and function of CF and also possibly suggests a
sustained release of antibiotic from the injectable self-
assembled biomimetic nanomatrix gel, which is effect-
ive against residual root canal bacteria. The results of
Figure 5B also indicated that a sustained release of anti-
biotic via self-assembled injectable biomimetic nanoma-
trix gel promote a greater bactericidal effect than one
time release of the antibiotics as seen in Figure 5A. Inter-
estingly, the results of MN against E. faecalis (Figure 4Affect of CF was measured in varying concentrations of 0 μg/mL,
ticola in concentrations of 2.0 × 106 CFU/mL, 2.0 × 107 CFU/mL and
ed in nanomatrix gel.
Figure 6 The Effect of metronidazole (MN) against T. denticola. Antibacterial effect of MN was measured in varying concentrations of 0 μg/mL,
0.0625 μg/mL, 0.125 μg/mL, 0.25 μg/mL, 0.5 μg/mL and 1 μg/mL on T. denticola in concentrations of 2.0 × 106 CFU/mL, 2.0 × 107 CFU/mL and
2.0 × 108 CFU/mL. A. Without nanomatrix gel, B. With antibiotic encapsulated in nanomatrix gel.
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and without injectable self-assembled biomimetic nano-
matrix gel; this reflected that MN may not be an effective
antibiotic choice for facultative anaerobic bacteria [38].
“In Figure 4B, the condition of the culture media and E.
faecalis together may interact with the nanomatrix gel
and affect the OD values of the experiment and this cul-
ture condition will be investigated further in the future
experiment.” However, MN may be the effective bacteri-
cidal agent in a complex of bacteria from the root canal
infection, which represents most of anaerobic bacteria.
When MN encapsulated injectable self-assembled bio-
mimetic nanomatrix gel was tested against T. denticola
(Figure 6A and B); bactericidal effect has shown success-
fully in the two lower T. denticola densities (2.0 ×
106 CFU/mL and 2.0 × 107 CFU/mL). In the density of
2.0 × 108 CFU/mL, T. denticola did not portray complete
bactericidal activity and this may be relatively low MN
concentrations compare to the bacterial load.
The key concept of our study is that the self-assembled
PAs can be mixed with antibiotics as a direct injectable
material into the infected root canal, which will provide
aseptic root canal and further provide a semi-natural
ECM environment. Although cellular viability of the bio-
mimetic nanomatrix gel for the dental pulp tissue has not
been studied yet; other studies have successfully shown ex-
cellent cellular biocompatibility, high level of cell conflu-
ence, and cell migration in cardiac tissues [16,39]. Our
current study will be an important fundamental step to as-
sess not only the effectiveness of MN and CF on infectious
root canal bacteria, but also the potential development of
the direct injectable self-assembled biomimetic nanoma-
trix gel to treat endodontic infections including necroticimmature teeth. As a next step, 1:1 combination of CF:
MN encapsulated within injectable self-assembled bio-
mimetic nanomatrix gel will be tested for a complex of
endodontic root canal bacteria from patient samples
in vitro and in vivo experiments. In addition, the charac-
teristics of antibiotic release from the biomimetic nanoma-
trix gels will be studied to explain the duration and
intensity of the antibiotic effects.
Conclusions
Concentrations (0.0625-0.25 μg/mL) of each CF and MN
encapsulated within the injectable biomimetic nanoma-
trix gel successfully demonstrated antibacterial activity
on E. faecalis and T. denticola. The proposed antibiotic
encapsulated injectable biomimetic nanomatrix gel sug-
gested an effective disinfecting and preconditioning root
canal treatment with numerous potential benefits as in-
novative endodontic materials.
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